Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci - Wikidata - wikimedia - TriplyDB

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

http://www.wikidata.org/entity/Q28236937

about

Chemotherapy for children with medulloblastoma Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease Dissecting the genomic complexity underlying medulloblastoma Significance and therapeutic value of miRNAs in embryonal neural tumors Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors Casein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesis.MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.Radiation-induced adult medulloblastoma: a two-case report and review of the literature.Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.Actionable molecular biomarkers in primary brain tumors.Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors.Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.Genetic alterations in microRNAs in medulloblastomas.Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.Distinct genomic aberrations between low-grade and high-grade gliomas of Chinese patients.Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.Molecular subgroups of medulloblastoma.Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.Establishment of a patient-derived orthotopic osteosarcoma mouse model Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.Multiple mechanisms of MYCN dysregulation in Wilms tumour.An animal model of MYC-driven medulloblastoma Clonal selection drives genetic divergence of metastatic medulloblastoma.Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.Myc proteins in brain tumor development and maintenance.MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.Novel cell lines established from pediatric brain tumors.Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement

P2860

Q24186770-FD23D123-6F8D-4D04-96DF-2F34DD3A30B3 Q24310764-CE2B298F-BD8E-4F3D-948D-77F0E158F222 Q24621907-91707AF5-7AF5-4C42-8723-2D867215EA48 Q26827171-54E72674-6F20-409E-9185-79A6B5733962 Q26866408-1DA405A7-6D2D-4FBA-9751-C2CAFDE41815 Q27320896-4B735D70-B7F4-47D4-A8E4-2F52DF8948C1 Q28083277-3C89AB49-DD75-4946-B516-C40CCD5ADA41 Q28282708-33D10018-D443-456A-AF33-F59F0AE2A7B6 Q28817295-87BAFF7F-3552-4CC8-98F2-D6F2E0D84282 Q33669523-BBCCC1E8-CA56-4BDA-9913-4B90CD6A550B Q33714780-4FC48464-9891-4A10-9145-A02527E3829B Q33764662-7B1C1642-7E5C-4589-BA37-78295EF02DDB Q33772355-0B0956C9-BA40-4821-A772-59AA224C808A Q34053468-1DFF6A17-ECB0-4FEC-8D15-DEC681CB735C Q34108929-B9524FF9-AAF2-47C0-AD4E-DB706BFE8E7D Q34166553-C7793A31-79F9-48FD-8A5F-8EB26C860A70 Q34167499-FE8F60DD-276C-4495-A3D3-420C97B269F3 Q34203950-B74AA915-90E4-485B-817D-5E7899C4EE0D Q34248736-867B205F-CE95-459A-B7BB-506BB68F1C03 Q34457533-F005710E-DBF6-4D6B-B528-A61840532D82 Q34603177-786EB431-9CE3-4860-B0A7-699314463FD1 Q34722504-E185EC3E-0574-4DCA-A173-09AA31AEFA2A Q34866372-8FC57D2A-7968-4989-BE7D-7A99A1E0BD08 Q35101347-233EB83C-C45A-4D90-A980-5F25F6219D91 Q35150189-FB952BA5-BCE1-4FA1-8946-E52482ACDBA0 Q35192672-90FE2B40-81A0-477C-84CD-919E2B398AD2 Q35246513-9A87BCA1-D4E0-4E75-8B39-036F0486C571 Q35595609-E47D2770-2340-43AA-AF02-B90A371B085C Q35696363-B234AF8D-06BB-4894-A153-5CEB428105A7 Q35740193-ABC6C25E-7C6A-444A-B6AC-4AA4A0F1F19E Q35774418-B300A35A-8379-46EE-B41A-F602C45BC1E7 Q35784926-5F35EADA-B9D5-4C98-B874-DA411129138A Q35837393-E3A3738B-7A32-43A3-BA3E-A22D1EF57E71 Q35914487-E0D4CC18-B488-4C3F-817E-DFBD4B6E08DA Q35920494-07216B7B-3661-44C5-934B-157059DE5E9B Q35925281-D9EAA35E-C760-4F94-9AB8-FFA197B08087 Q35960250-FDDDC7DE-87F1-412E-8D15-97307198EF25 Q35989886-64E16034-9621-4A17-8651-8B9F20778D31 Q36047046-699CAD22-6F7E-4AA9-8696-E9FC1CC21599 Q36048155-666DC6C6-FA87-4F0E-8C7D-6B7453793D51

P2860

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

http://www.wikidata.org/entity/Q28236937

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@ast

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@en

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@nl

type

label

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@ast

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@en

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@nl

prefLabel

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@ast

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@en

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@nl

P1433

Q28236937-11E27B8A-BCFE-4739-926A-9F17530A1D12

P1476

Q28236937-699D254E-881E-4F8F-B51D-EC07F7544954

P2093

Q28236937-115EB275-931D-43FE-9937-503F1693E7AA

Q28236937-17EF4B27-1E8A-473C-B25B-153EF9DB08E9

Q28236937-1AD297E0-48E3-406B-B037-47998860096F

Q28236937-39BC2F2C-208C-49C7-BC02-1ACBC121506B

Q28236937-3D92E285-3482-49E7-B262-AB7804ED3A51

Q28236937-462338BE-742E-4314-A288-F0A55440C344

Q28236937-61E49C65-C378-4B17-8C67-534A9C482324

Q28236937-68CE5A52-18D5-4FB3-AFC8-33D0A69C849E

Q28236937-7A4D96B9-478C-48A1-9BB0-A2777B4B0C2A

Q28236937-8C1EC7A2-0E9B-4514-B8AE-F6D2CBB8830F

P304

Q28236937-F4FE4B7A-6E7A-48D7-A84A-38E465B747C0

P31

Q28236937-880B5A4F-1323-4F43-843D-9B9D982CD3ED

P3181

Q28236937-BEC12EE1-55AA-484A-BDAE-B60CDEA5561C

P356

Q28236937-11928D9D-6363-42C0-8CC1-1BACE415B13A

P407

Q28236937-34929C2A-532C-4E02-ACD8-E19F16D15EFD

P433

Q28236937-5AE44118-70CB-4979-9FB1-836672E4D2F4

P478

Q28236937-95A29EE4-4589-41BC-99D4-C62A0B914A46

P50

Q28236937-06A2B29E-3747-4E2B-A008-21C6087143CA

Q28236937-2713671C-28D2-492E-A6E8-73BAAFB9FB5B

Q28236937-72EAFBBD-80F7-42B0-83F4-4322658B7836

Q28236937-A691F578-6F64-4F6D-B4E4-B2FCD458B25A

Q28236937-ADF6DAF7-8177-4FED-AC35-16BC893964CC

Q28236937-E3318FC7-776B-442C-8A13-966F90A90D37

P577

Q28236937-356E6EE8-C12E-4CDF-B3F5-AB25813DF898

P698

Q28236937-3C4E4A06-F04B-4DF5-A028-3805F1590B1D

P921

Q28236937-980E280E-D0EB-413A-9C7D-4F4A0770C71C

P3181

P356

JCO.2008.17.9432

P1433

Journal of Clinical Oncology

P1476

Outcome prediction in pediatri ...... 17q and the MYC and MYCN loci

@en

P2093

Andrea Wittmann

http://www.w3.org/2001/XMLSchema#string

Andreas Kulozik

http://www.w3.org/2001/XMLSchema#string

Andrey Korshunov

http://www.w3.org/2001/XMLSchema#string

Axel Benner

http://www.w3.org/2001/XMLSchema#string

Frank Mendrzyk

http://www.w3.org/2001/XMLSchema#string

Frauke Devens

http://www.w3.org/2001/XMLSchema#string

Grischa Toedt

http://www.w3.org/2001/XMLSchema#string

Nicolas U Gerber

http://www.w3.org/2001/XMLSchema#string

Otmar D Wiestler

http://www.w3.org/2001/XMLSchema#string

Stefan Joos

http://www.w3.org/2001/XMLSchema#string

P304

1627-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4578869

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2008.17.9432

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Guido Reifenberger

Bernhard Radlwimmer

Stefan M Pfister

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19255330

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma